Zepbound (tirzepatide) is a once weekly injectable medication that works on two hormone pathways, GIP and GLP-1, to reduce appetite, slow stomach emptying, and support weight loss
At first glance, those numbers reflect healthy year-over-year increases, as Mounjaro sales more than doubled, zooming 121% from $1.409 billion in July-September 2023
Nausea and diarrhea were common gastrointestinal side effects that occasionally caused people to stop taking the medication
Other Considerations Hyperpigmentation: Minimal compared to Melanotan II due to reduced MC1R affinity and intermittent dosing Long-term safety: Data spanning up to one year has not revealed unexpected adverse events or cumulative toxicity Pregnancy: Category not established
Complementary: Biocrates p400 kit Ready-to-use 96-well plate oormat oor high-throughput acylcarnitine + amino acid + lipid quantioication when sample volume is limited and throughput is prioritized